NICE Guidance Expected To Add 1.4 Million To Roster Of Statin Users
Executive Summary
An additional 1.4 million patients in England and Wales are expected to begin using statins as a result of guidance directing doctors to identify patients at high-risk for cardiovascular disease
You may also be interested in...
Merck/Schering Vytorin Launch Could Be Aided By New Cholesterol Guidelines
Revised cholesterol treatment guidelines could result in increased use of combination lipid-lowering therapies as Merck/Schering-Plough's Vytorin enters the market
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
Track-And-Trace: With Deadline a Year Away, Some Lessons from Early Adopters
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.